Michael David Seckler - 08 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Commercial Officer
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol
CRMD
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
15 Jan 2026, 21:30:02 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Seckler Michael David Chief Commercial Officer C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Beth Zelnick Kaufman, attorney-in-fact 15 Jan 2026 0002105167

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +133,156 $0.000000 133,156 08 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Restricted Stock Units were granted on 01/08/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.